Should prescriptions travel borders? - A renewed look at drug re-importation

    HALIFAX, Sept. 20 /CNW/ - The United States cannot solve its "Medicare
donut hole" through Canada's back door. That's the conclusion of a new health
care paper published by the Atlantic Institute for Market Studies (AIMS). It
points out that as Americans head into an election year, drug re-importation
will likely become an issue, particularly with several states actively
promoting the re-importation of prescription drugs from Canada as a method to
control Medicare costs.
    "We should be concerned when American politicians start using
re-importation of Canadian drugs as a political smokescreen. A policy of
controlling US drug costs by shipping drugs north to Canada and hoping that
they will still be cheap when they come back into the United States is on a
par with asking the tooth fairy to provide a national dental service on the
grounds that it will be self-financing," writes author Brian Ferguson, AIMS
Fellow in Health Care Economics and a professor of economics at the University
of Guelph.

    To read the complete report, visit or the detailed release at

For further information:

For further information: Barbara Pike, AIMS Director of Communications,
(902) 429-1143, (902) 452-1172

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890